CYP3A4 PROTEIN, HUMAN

Clinical trials for CYP3A4 PROTEIN, HUMAN explained in plain language.

Never miss a new study

Get alerted when new CYP3A4 PROTEIN, HUMAN trials appear

Sign up with your email to follow new studies for CYP3A4 PROTEIN, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New test could predict dangerous side effects of common breast cancer drugs

Knowledge-focused ENROLLING_BY_INVITATION

This study aims to develop a test to predict which breast cancer patients might experience severe side effects or poor response to a common class of drugs called CDK4/6 inhibitors. Researchers will analyze blood samples and genetic information from 100 female patients taking thes…

Matched conditions: CYP3A4 PROTEIN, HUMAN

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused

Last updated Mar 24, 2026 12:02 UTC

CYP3A4 PROTEIN, HUMAN

Get alerted when new CYP3A4 PROTEIN, HUMAN trials appear

New test could predict dangerous side effects of common breast cancer drugs